title: Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
authors.affiliation: Medical Clinic, University of Heidelberg, FRG.
authors.forename: J
authors.initials: J
authors.lastname: Bommer
authors.forename: M
authors.initials: M
authors.lastname: Kugel
authors.forename: W
authors.initials: W
authors.lastname: Schoeppe
authors.forename: R
authors.initials: R
authors.lastname: Brunkhorst
authors.forename: W
authors.initials: W
authors.lastname: Samtleben
authors.forename: P
authors.initials: P
authors.lastname: Bramsiepe
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
mesh_terms: D000328:Adult; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004920:Erythropoiesis; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin